“decrease same term”的搜索结果，显示 1251-1260 项，共有 5377 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... same day postradioembolization study-specific non-FDG PET/CT scan. Correlate this measurement with mean lobar absorbed radiation dose and embolic load given ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   GENetic Risk Estimation of Breast Cancer Prior to Decisions on Preventive Therapy Uptake, Risk Reducing Surgery or Intensive Imaging Surveillance ... Equal To 18 ...

3. 血液科- 临床试验- 妙佑医疗国际

   This clinical trial is studying long-term follow-up in patients who are or have participated in Children's Oncology Group studies. Developing a way to track ...

4. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma ...

5. 神经科- 临床试验- 妙佑医疗国际

   This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing neurocognitive ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... same day postradioembolization study-specific non-FDG PET/CT scan. Correlate this measurement with mean lobar absorbed radiation dose and embolic load given ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... reducing the risks of IIC remains largely unknown. Given that this is a small pilot study to generate preliminary data, there will be no randomization in ...

8. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to find out more about the side effects of the CAR-T therapy called IC19/1563 and what dose of IC19/1563 is safe ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...

10. 血液科- 临床试验- 妙佑医疗国际

    Rochester, Minn. The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma ...